Shi, V Y, Bhutani, T, Fonacier, L, Deleuran, M, Shumack, S, Valdez, H, Zhang, F, Chan, G L, Cameron, M C & Yin, N C 2022, ' Phase 3 Efficacy and Safety of Abrocitinib in Adults with Moderate-to-Severe Atopic Dermatitis After Switching from Dupilumab (JADE EXTEND) ', Journal of the American Academy of Dermatology, vol. 87, no. 2, pp. 351-358 . https://doi.org/10.1016/j.jaad.2022.04.009